Overview
Dr. John Bisognano is a Clinical Professor of Internal Medicine and Interim Chief of the Division of Cardiovascular Medicine. Dr. Bisognano earned his bachelor's degree from MIT, his MA in chemistry and PhD in physical chemistry from SUNY-Binghamton University, and his MD from SUNY-Upstate Medical College. Dr. Bisognano completed his internal medicine residency at the University of Michigan where his interest in cardiology and hypertension was ignited by Dr. Stevo Julius. After completing a fellowship in hypertension, Dr. Bisognano moved to Colorado to complete a fellowship in cardiology and advanced heart failure and transplant at the University of Colorado.Dr. Bisognano returned to the University of Michigan where he was an Assistant Professor of Internal Medicine for several years before joining the new heart transplant team at the University of Rochester in 2001. While there, he served in numerous leadership roles, including Director of Cardiac Rehabilitation, Medical Director of the University’s Accountable Care organization, and Director of Outpatient Cardiology. In 2021, Dr. Bisognano returned to the University of Michigan and joined faculty in the Division of Cardiovascular Medicine as a clinical professor. He was named the division's interim chief in 2023.Dr. Bisognano sees patients on the inpatient cardiology services, the inpatient consultative service, and in outpatient clinics. His area of specialty includes general cardiology, as well as severe and resistant hypertension, lipid management, and management of patients with chronic heart failure and ischemic coronary and vascular disease.A significant part of Dr. Bisognano’s career has been dedicated to general cardiology. He has a longstanding interest in severe and refractory hypertension including device-based therapies for hypertension and is the author of more than 115 journal articles, three books, and numerous book chapters. Dr. Bisognano has served as PI on an NIH R01 grant related to behavioral interventions in people with mild hypertension. He currently serves as co-investigator on an NIH R61/R33 grant for community-based interventions in hypertension.Dr. Bisognano has served as President of the American Society of Hypertension, Vice-Chair of the American Heart Association Council on High Blood Pressure, Upstate New York State Governor of the American College of Cardiology, and President of the New York Cardiovascular Society.Dr. Bisognano has been recognized with numerous honors and awards including the University of Rochester Kuhn Teaching Fellowship for Outstanding Medical Student Teaching, the University of Rochester Medical Center Board Excellence Award, and the American Heart Association Arthur J. Moss Award.
Dr. Bisognano is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hypertension, Aortic Valve Stenosis, Glucocorticoid-Remediable Aldosteronism, Pacemaker Implantation, and Cardiac Ablation.
Dr. Bisognano is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure & Transplant Cardiology. He is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 3 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
24 Frank Lloyd Wright Dr. Ste 1300, Lobby A, Ann Arbor, MI 48106
7500 Challis Rd, Entrance 1, Level 2, Brighton, MI 48116
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Frankel Cardiovascular Center
Dr. Hummel is the Director for Heart Failure with Preserved Ejection (HFpEF) program at the Frankel Cardiovascular Center. The HFpEF clinical program incorporates multi-domain assessment and management, with the goals of improving quality of life and long-term outcomes while uncovering and treating the underlying causes of this complex syndrome. The Michigan Medicine HFpEF program also offers access to groundbreaking clinical trials which incorporate interventions ranging from dietary support and medications to implantable cardiac devices for HFpEF. In addition to industry-sponsored trials, Dr. Hummel’s own research has been funded by the NHLBI, NIA, AHRQ, and the VA. This work aims to understand the impact of diet on HFpEF development and progression, and to facilitate healthy eating through technological innovation.As part of the American College of Cardiology’s Geriatric Cardiology leadership council, Dr. Hummel also studies the importance of geriatric domains, such as malnutrition, frailty, and polypharmacy, in heart failure assessment and management. Dr. Hummel is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Heart Transplant, and Cardiac Ablation. Dr. Hummel is board certified in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology.
Frankel Cardiovascular Center
Todd Koelling joined the University of Michigan faculty in 1997. At present, Dr. Koelling is the Medical Director of Heart Failure and co-directs the Heart Failure and Heart Transplantation Management Program at the University of Michigan. He is a Professor in the Department of Internal Medicine. His research interests include heart failure quality improvement, heart failure management, and risk/prognosis assessment. He has studied targeted patient education interventions in heart failure patients and has directed community hospital quality improvement initiatives in the State of Michigan. He is committed to improving the quality of care provided to patients with advanced heart failure treated at the University of Michigan Health System. Dr. Koelling is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiomyopathy, Sarcoidosis, Heart Transplant, and Heart Valve Repair. Dr. Koelling is board certified in Advanced Heart Failure & Transplant Cardiology.
Briarwood Health Associates
Keith Aaronson, MD, PhD, MS, is the Bertram Pitt, MD Collegiate Professor of Cardiovascular Medicine and Professor of Internal Medicine in the Division of Cardiovascular Medicine, University of Michigan Medical School, the Medical Director of the Cardiac Transplant Service and the Center for Circulatory Support and the Co-Director of the Heart Failure and Transplant Management Program for Michigan Medicine. Dr. Aaronson is actively engaged in clinical practice and clinical research in the areas of heart failure, heart transplantation and mechanical circulatory support. His research has focused on improving health, quality of life and economic outcomes in these populations, utilizing methodologies ranging from small to large scale observational analyses, Markov modeling, meta-analyses, and both industry-sponsored and investigator-initiated randomized clinical trials of standard pharmaceutical interventions, alternative medicines, patient education and mechanical circulatory support. Dr. Aaronson has had a particular interest in modeling outcomes in advanced heart failure, heart transplantation and mechanical circulatory support to inform appropriate utilization of health resources. He co-developed the first prospectively validated survival model for patients with advanced heart failure, the Heart Failure Survival Score, which remains in use by heart failure specialists worldwide to help select the most appropriate candidates for heart transplantation and other advanced therapies. He was national Co-PI of the completed HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial, the NHLBI-funded REVIVE-IT trial and the ongoing REVIVAL registry. His present research includes investigations of novel devices for percutaneous circulatory support, cardiac remodeling and cardiorenal syndrome. Dr. Aaronson is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Heart Failure, Pulmonary Edema, Cardiomyopathy, Heart Transplant, and Atherectomy. Dr. Aaronson is board certified in Internal Medicine and Advanced Heart Failure & Transplant Cardiology.
Frequently Asked Questions about Dr. John D. Bisognano
How do I make an appointment with Dr. John D. Bisognano?
You can book an appointment with Dr. John D. Bisognano by calling their office at 888-287-1082. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John D. Bisognano a top-rated expert for Hypertension?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John D. Bisognano is classified as an Distinguished expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John D. Bisognano specialize in?
While Dr. John D. Bisognano is a Cardiology, they have specific expertise in Hypertension, Aortic Valve Stenosis, and Glucocorticoid-Remediable Aldosteronism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.
Does Dr. John D. Bisognano participate in research or clinical trials?
Yes. Dr. John D. Bisognano has published 56 articles and abstracts on conditions like Hypertension. You can view a list of Dr. John D. Bisognano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John D. Bisognano accept my insurance?
Dr. John D. Bisognano accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-287-1082 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HypertensionDr. Bisognano isDistinguished. Learn about Hypertension.
- Advanced
- AnginaDr. Bisognano isAdvanced. Learn about Angina.
- Aortic Valve StenosisDr. Bisognano isAdvanced. Learn about Aortic Valve Stenosis.
- AtherosclerosisDr. Bisognano isAdvanced. Learn about Atherosclerosis.
- Atrial FibrillationDr. Bisognano isAdvanced. Learn about Atrial Fibrillation.
- Coronary Heart DiseaseDr. Bisognano isAdvanced. Learn about Coronary Heart Disease.
- Glucocorticoid-Remediable AldosteronismDr. Bisognano isAdvanced. Learn about Glucocorticoid-Remediable Aldosteronism.
- Experienced
- Adenosine Deaminase 2 DeficiencyDr. Bisognano isExperienced. Learn about Adenosine Deaminase 2 Deficiency.
- Aortic RegurgitationDr. Bisognano isExperienced. Learn about Aortic Regurgitation.
- ApoplexyDr. Bisognano isExperienced. Learn about Apoplexy.
- ArrhythmiasDr. Bisognano isExperienced. Learn about Arrhythmias.
- Arterial EmbolismDr. Bisognano isExperienced. Learn about Arterial Embolism.
- Atrial TachycardiaDr. Bisognano isExperienced. Learn about Atrial Tachycardia.